According to a new market research report, the High Performance Medical Plastics Market by Type (FP, HPPA, PAEK, PPS, PEI), Application (Medical Supplies, Medical Equipment & Tools, Drug Delivery, Prosthesis & Implants, Therapeutic System), Region – Global Forecast to 2026″, size is projected to grow from USD 851 million in 2021 to USD 1,242 million by 2026, at a CAGR of 7.8% during the forecast period 2021 to 2026. Increasing use of high performance medical plastics in advanced medical technology in implants, precision medicines, smart inhalers, artificial organs, customized minimally invasive devices, and robotic assistance in surgical operations are propelling the demand for high performance medical plastics across the globe.

Download PDF Brochure:


  • 124 Market data Tables
  • 46 Figures
  • 209 Pages and in-depth TOC on “High Performance Medical Plastics Market – Global Forecast to 2026″

This report also provides a comprehensive analysis of the companies listed below:

Solvay SA (Belgium), SABIC (UAE), Mitsubishi Chemical Corporation (Japan), Evonik Industries AG (Germany), Arkema SA (France), Ensinger (Germany), Victrex PLC (UK), Rochling SE & Co. AG (Germany), Raumedic AG (Germany), The Chemours Company (US), DuPont (US), Saint-Gobain Performance Plastics (France), Celanese Corporation (US), Trelleborg (Sweden) and Tekni-Plex (US), among others.

These players have adopted the strategies of acquisitions and partnerships to enhance their position in the market.

The growing use of advanced medical technologies, such as 3D printed implants and customized devices is one of the major factor propelling the growth of the high performance medical plastics market.

Solvay SA
 is the largest company in the global high performance medical plastics market. High performance plastics are a part of the materials business segment of the company. Solvay SA operates through 428 subsidiaries in 64 countries of Europe, North America, Latin America, and Asia-Pacific. The company has 119 operational facilities worldwide. As a global leader in materials, chemicals, and solutions, Solvay brings advancements in planes, cars, batteries, smart and medical devices, and water and air treatment, to solve critical industrial, social, and environmental challenges. Solvay SA, in December 2020 entered into a partnership with PrinterPrezz (US) to develop 3D printing Selective Laser Sintering (SLS) solutions for implants and other medical devices using high performance polymers.

Another important player in the high performance medical plastics market is Evonik Industries AG. The company has vast experience in manufacturing high performance medical plastics and a broad product portfolio, huge production capacity, and sales, logistics, and technical service network. Evonik has a dedicated section for medical plastic division and products like VESTAKEEP, VESTAMID and TRAGOMID care have application in dental applications, body implants and medical devices. Evonik is one of the world leaders in specialty chemicals. Evonik goes far beyond chemistry to create innovative, profitable, and sustainable solutions for customers. The company has done major acquisitions and joint ventures with companies like Durect Corporation and Wynka Silicon for increasing its high performance medical plastics market.

Inquire Now

Download PDF Brochure of Trending Upcoming Reports: